Gemini Bio

Executive Summary

Gemini Bio is a well-established provider of critical cell culture and process liquid solutions for the biotechnology industry, with a focus on cell therapy and biomanufacturing. Founded in 1985 and operating two cGMP manufacturing facilities certified to ISO 13485 and FDA standards, the company specializes in Human AB Serum, custom media and buffers, and high-purity water systems. As the cell therapy market expands, Gemini Bio is well-positioned to benefit from increased demand for high-quality raw materials and custom solutions. Its long track record, regulatory compliance, and expertise in supporting workflows from research through commercial production give it a competitive advantage in the growing bioprocessing sector. The company's established customer base and reputation for reliability underpin its potential for steady growth.

Upcoming Catalysts (preview)

• TBDExpansion of custom media product line for emerging cell therapies75% success
• TBDStrategic partnership with a major biopharma for Human AB Serum supply60% success
• TBDCompletion of facility upgrade to increase cGMP production capacity70% success